Abstract: A display device includes a controller configured to perform control of bringing a predetermined number of adjacent openings into a first state being one state of a light transmitting state and a light shielding state to form a plurality of first state parts. The controller changes a potential of all of a plurality of electrodes to any of a first potential, a predetermined potential between the first potential and a second potential, and the second potential. After the change, the controller moves the first state parts.

Abstract: In the case that a first scanning line having a smaller number of pixels to be driven than that of a second scanning line in a display device having a heteromorphic display region, capacitance is added to an extended scanning line in which the first scanning line extends to an outside of the display region. A large difference in RC delay between scanning lines generated by the number of pixels to be driven can be compensated for by adding the capacitance, so that luminance unevenness can be prevented to contribute to improvement of display quality.

Abstract: A recognition device mounted on a vehicle to recognize a traveling area in which the vehicle travels, the recognition device comprising: an edge detection unit for detecting an edge line that defines one edge of the traveling area in a lateral direction orthogonal to a traveling direction of the vehicle; an object detection unit for detecting a position of a moving object existing in front of the vehicle in the traveling direction; and a correction unit for correcting, when the moving object is positioned between the vehicle and the edge line in the lateral direction, a position in the lateral direction of the edge line detected by the edge detection unit to a position between the vehicle and the moving object, or to a position within a width of the moving object.

Abstract: In the case that a first scanning line having a smaller number of pixels to be driven than that of a second scanning line in a display device having a heteromorphic display region, capacitance is added to an extended scanning line in which the first scanning line extends to an outside of the display region. A large difference in RC delay between scanning lines generated by the number of pixels to be driven can be compensated for by adding the capacitance, so that luminance unevenness can be prevented to contribute to improvement of display quality.

Abstract: A liquid crystal display device includes a display region, a plurality of lead-out lines led from the display region, and an application circuit that applies a voltage to liquid crystal in the display region through each of the lead-out lines. Each of the lead-out lines has a tilt portion wired with a directional component parallel to a peripheral direction enclosing the display region in a plan view, and when a difference between a voltage applied to one of the lead-out lines and a voltage applied to another one of the lead-out lines is specified as an applied voltage difference, each of the lead-out lines is wired such that, in a plan view, the taper portion of one of the lead-out lines is overlapped with the taper portion of another one of the lead-out lines having the applied voltage difference lower than a difference with adjacent one of the lead-out lines.

Abstract: A liquid crystal display device includes a display region, a plurality of lead-out lines led from the display region, and an application circuit that applies a voltage to liquid crystal in the display region through each of the lead-out lines. Each of the lead-out lines has a tilt portion wired with a directional component parallel to a peripheral direction enclosing the display region in a plan view, and when a difference between a voltage applied to one of the lead-out lines and a voltage applied to another one of the lead-out lines is specified as an applied voltage difference, each of the lead-out lines is wired such that, in a plan view, the taper portion of one of the lead-out lines is overlapped with the taper portion of another one of the lead-out lines having the applied voltage difference lower than a difference with adjacent one of the lead-out lines.

Abstract: A liquid crystal display device according to the present invention is a liquid crystal display device in which liquid crystals are sealed between a TFT array substrate, and a counter substrate formed with a counter electrode. A plurality of scanning signal wirings and a plurality of image signal wirings are formed in a matrix on the TFT array substrate. The counter electrode is configured from a plurality of counter electrode lines. Each of the plurality of counter electrode lines is provided along a corresponding one of the plurality of scanning signal wirings or a corresponding one of the plurality of image signal wirings in plan view. Each of the plurality of counter electrode lines has a potential distribution in an extending direction. The respective potential distributions for the plurality of counter electrode lines are different.

Abstract: A liquid crystal display device according to the present invention is a liquid crystal display device in which liquid crystals are sealed between a TFT array substrate, and a counter substrate formed with a counter electrode. A plurality of scanning signal wirings and a plurality of image signal wirings are formed in a matrix on the TFT array substrate. The counter electrode is configured from a plurality of counter electrode lines. Each of the plurality of counter electrode lines is provided along a corresponding one of the plurality of scanning signal wirings or a corresponding one of the plurality of image signal wirings in plan view. Each of the plurality of counter electrode lines has a potential distribution in an extending direction. The respective potential distributions for the plurality of counter electrode lines are different.

Abstract: A transflective type liquid crystal display device according to an exemplary aspect of the invention includes: a liquid crystal layer; a first sub-pixel electrode that is constituted of a transmissive region transmitting light from a back surface side to a display surface side; a second sub-pixel electrode that is constituted of a reflective region reflecting light being incident from the display surface side; and a connecting portion that electrically connects the first sub-pixel electrode and the second sub-pixel electrode to each other. The second sub-pixel electrode being constituted of the reflective region that is adjacent to the first sub-pixel electrode being constituted of the transmissive region has a reflective conductive thin film in which a hollowed out cutout portion is formed, in a region extending from the connecting portion connecting the first sub-pixel electrode and the second sub-pixel electrode to each other.

Abstract: A transflective type liquid crystal display device according to an exemplary aspect of the invention includes: a liquid crystal layer; a first sub-pixel electrode that is constituted of a transmissive region transmitting light from a back surface side to a display surface side; a second sub-pixel electrode that is constituted of a reflective region reflecting light being incident from the display surface side; and a connecting portion that electrically connects the first sub-pixel electrode and the second sub-pixel electrode to each other. The second sub-pixel electrode being constituted of the reflective region that is adjacent to the first sub-pixel electrode being constituted of the transmissive region has a reflective conductive thin film in which a hollowed out cutout portion is formed, in a region extending from the connecting portion connecting the first sub-pixel electrode and the second sub-pixel electrode to each other.

Abstract: A mounting terminal substrate includes a substrate, mounting terminals arranged in staggered rows on the substrate, each mounting terminals includes a lower conductive film and an upper conductive film, lines that are provided between the mounting terminals in a direction of a row, an insulation film that covers the lines, and opening sections on the respective mounting terminals from which the insulation films are removed, wherein a width of the upper conductive film in the direction of the row is greater than a width of the lower conductive film in the direction of the row so as to cover the lower conductive films exposed through the opening sections and is equal to or smaller than a width of the opening section in the direction of the row.

Abstract: The present invention relates to compounds represented by formula (1) and a process for producing the same. The use of these compounds can realize the production of carbapenem derivatives having potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost-effective manner.

Abstract: The present invention relates to compounds represented by formula (1) and a process for producing the same. The use of these compounds can realize the production of carbapenem derivatives having potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost-effective manner.

Abstract: A mounting terminal substrate includes a substrate, mounting terminals arranged in staggered rows on the substrate, each mounting terminals includes a lower conductive film and an upper conductive film, lines that are provided between the mounting terminals in a direction of a row, an insulation film that covers the lines, and opening sections on the respective mounting terminals from which the insulation films are removed, wherein a width of the upper conductive film in the direction of the row is greater than a width of the lower conductive film in the direction of the row so as to cover the lower conductive films exposed through the opening sections and is equal to or smaller than a width of the opening section in the direction of the row.

Abstract: The present invention relates to compounds represented by formula (1) and a process for producing the same. The use of these compounds can realize the production of carbapenem derivatives having potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost-effective manner.

Abstract: The present invention relates to compounds represented by formula (1) and a process for producing the same. The use of these compounds can realize the production of carbapenem derivatives having potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost-effective manner.

Abstract: Disclosed is a process for efficiently producing a compound represented by formula (I): wherein R1 represents aryl, amino, alkyl, or alkoxy; R2 represents a protective group of the carboxylic acid; and R3 represents an alkali metal, a hydrogen atom, alkyl, aryl, alkylsulfonyl, arylsulfonyl, or trialkylsilyl. This process is characterized by reacting a compound of formula (II) with a compound of formula (III) in the presence of a transition metal compound.

Abstract: An objective of the present invention is to provide a transformant altered so as to produce a secondary metabolite in which a benzene ring of the secondary product is modified at the para-position with a functional group containing a nitrogen atom.

Abstract: Disclosed is a process for efficiently producing a compound represented by formula (I): wherein R1 represents aryl, amino, alkyl, or alkoxy; R2 represents a protective group of the carboxylic acid; and R3 represents an alkali metal, a hydrogen atom, alkyl, aryl, alkylsulfonyl, arylsulfonyl, or trialkylsilyl. This process is characterized by reacting a compound of formula (II) with a compound of formula (III) in the presence of a transition metal compound.

Abstract: Compounds represented by the following formula (I) and pharmaceutically acceptable salts thereof are disclosed. The compounds have progesterone receptor binding inhibitory activity and, hence, can be used as therapeutic and prophylactic agents for progesterone-related diseases. Specifically, they are useful as abortifacients, oral contraceptive pills, carcinostatic agents for breast cancer and ovarian cancer, therapeutic agents for endometriosis, meningioma, and myeloma, and therapeutic and prophylactic agents for osteoporosis and climacteric disturbance.